{"id":"W4414680807","doi":"10.1101/2025.09.27.25336656","title":"Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease Patients","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dynacast (Canada); Toronto Western Hospital; University of British Columbia Hospital; Bruyère; Baycrest Hospital; Parkwood Institute; University of British Columbia; Island Health","funders":"Grifols; Novo Nordisk; Eisai; Biogen; TauRx Pharmaceuticals; Alnylam Pharmaceuticals; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Precision medicine; Disease; Quality of life (healthcare); Clinical trial; Placebo; Neurology; Population; Randomized controlled trial; Biomarker","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001333595,0.0009731631,0.001481898,0.0002284934,0.0003532067,0.0005914566,0.0004181995,0.0008050841,0.008039935],"category_scores_gemma":[0.0007479902,0.0002661651,0.001098401,0.0002220978,0.000412663,0.0003687778,0.0002317613,0.001256278,0.0008063736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005080753,"about_ca_system_score_gemma":0.0007648767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008262387,"about_ca_topic_score_gemma":0.002774179,"domain_scores_codex":[0.9996463,0.0001762308,0.00002090358,0.00006400615,0.00002907572,0.00006347233],"domain_scores_gemma":[0.9995628,0.00008690597,0.0001024962,0.00005038546,0.00005374831,0.0001436965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9548982,0.006608194,0.001737359,0.0004075916,0.0007832606,0.00004576616,0.00004063145,0.0001475024,0.009706698,0.00009434348,0.001809462,0.02372088],"study_design_scores_gemma":[0.8572134,0.121447,0.01557012,0.00005336291,0.001161591,0.0000824517,0.00003036053,0.0002259658,0.00183818,0.0001924998,0.002168854,0.00001634841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851347,0.003996785,0.0004731,0.0005253426,0.0001772948,0.003110871,0.002931703,0.00009365893,0.00355643],"genre_scores_gemma":[0.9877056,0.00135934,0.001248155,0.0008890765,0.0001737154,0.002550368,0.002852266,0.00001436954,0.003207069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008039935,"threshold_uncertainty_score":0.02689624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5009719224652109,"score_gpt":0.5185176433627965,"score_spread":0.01754572089758555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}